Home / Inspections / 1210326

FDA Inspection 1210326 — Leslie S. Baumann, M.D.

Leslie S. Baumann, M.D. — FEI 3003701843

The FDA completed an inspection of Leslie S. Baumann, M.D. on July 12, 2023 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 12, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)

Facility

Other inspections at this facility

  • 1003101 (NAI Wed Mar 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 974714 (NAI Thu Jun 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 888822 (NAI Wed Jul 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 827635 (NAI Thu Feb 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 777447 (NAI Thu Apr 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources